Commentary: A Human Pluripotent Stem Cell-Based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids

Commentary: A Human Pluripotent Stem Cell-Based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids

Bibliographic Details
Main Authors:	Amin Ardestani, Kathrin Maedler
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-10-01
Series:	Frontiers in Endocrinology
Subjects:	COVID-19 SARS-CoV-2 diabetes beta-cell inflammation cytokine storm
Online Access:	https://www.frontiersin.org/article/10.3389/fendo.2020.585922/full

Similar Items

Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?—Lessons Learned From Cancer
by: Antonio Barbieri, et al.
Published: (2020-09-01)

Dysregulated immune response in SARS-CoV-2 infections
by: Marilaeta Cindryani, et al.
Published: (2020-01-01)

Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions
by: Mai M. Abdelmoaty, et al.
Published: (2021-10-01)

Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells
by: Bahareh Hafezi, et al.
Published: (2021-07-01)

Cytokine Response in SARS-CoV-2 Infection in the Elderly
by: Sherwani S, et al.
Published: (2020-10-01)

Cytokine storm of a different flavour: The different cytokine signature of SARS-CoV-2, the cause of COVID-19, from the original SARS outbreak
by: Daniel O. Griffin, et al.
Published: (2021-03-01)

Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery
by: Alice Maria Giani, et al.
Published: (2021-05-01)

Pathogenetic rationale for the use of cell therapy in lung injury associated with SARS-CoV-2
by: A. I. Stukan, et al.
Published: (2020-06-01)

Immunomodulatory drug therapy for the disease caused by SARS-CoV-2 infection (COVID-19)
by: D. E. Karateev, et al.
Published: (2020-09-01)

Flavonoids against the SARS-CoV-2 induced inflammatory storm
by: Alena Liskova, et al.
Published: (2021-06-01)

Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm
by: Alexandra Pum, et al.
Published: (2021-01-01)

SARS-COV-2 Infection and Kawasaki Disease: Case Report of a Hitherto Unrecognized Association
by: Marco Cazzaniga, et al.
Published: (2020-07-01)

Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell–Derived Intestinal OrganoidsSummary
by: Jana Krüger, et al.
Published: (2021-01-01)

The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis
by: Angela Dziedzic, et al.
Published: (2021-02-01)

Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2
by: Nikola Hudakova, et al.
Published: (2021-05-01)

Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
by: Corrado Pelaia, et al.
Published: (2021-03-01)

Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications
by: Alessandro Allegra, et al.
Published: (2020-07-01)

Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications
by: Rowaiye AB, et al.
Published: (2021-04-01)

SARS-CoV-2: From the pathogenesis to potential anti-viral treatments
by: Peyman Kheirandish Zarandi, et al.
Published: (2021-05-01)

Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis
by: Adriana Albini, et al.
Published: (2021-09-01)

Case Report: Tocilizumab for the Treatment of SARS-CoV-2 Infection in a Patient With Aplastic Anemia
by: Gina Keiffer, et al.
Published: (2020-09-01)

The Immunopathogenesis of Neuroinvasive Lesions of SARS-CoV-2 Infection in COVID-19 Patients
by: Shamila D. Alipoor, et al.
Published: (2021-07-01)

Understanding the immunopathology of SARS-CoV-2 infection - the key to successful COVID-19 therapy
by: Ewa Brzezińska-Błaszczyk, et al.
Published: (2021-04-01)

The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review
by: Subham Das, et al.
Published: (2021-06-01)

COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks
by: Markus Blaess, et al.
Published: (2020-07-01)

SARS-CoV-2: characteristics and current advances in research
by: Yicheng Yang, et al.
Published: (2020-07-01)

The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences
by: Amal F. Alshammary, et al.
Published: (2021-01-01)

Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19
by: Reza Zolfaghari Emameh, et al.
Published: (2020-07-01)

Phytochemicals as Potential Therapeutics for SARS-CoV-2–Induced Cardiovascular Complications: Thrombosis and Platelet Perspective
by: Samir K. Beura, et al.
Published: (2021-04-01)

Potential Therapeutic Effect of Micrornas in Extracellular Vesicles from Mesenchymal Stem Cells against SARS-CoV-2
by: Jae Hyun Park, et al.
Published: (2021-09-01)

Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection
by: Mar Pacheco-Herrero, et al.
Published: (2021-04-01)

Red face may be a specific sign of SARS-CoV-2 alpha variant
by: Aya Nakaya, et al.
Published: (2021-01-01)

The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner
by: Victoria Callahan, et al.
Published: (2021-06-01)

Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce <i>IL6</i> in Monocytes and Macrophages—Potential Implications for Cytokine Storm Syndrome
by: Iwona Karwaciak, et al.
Published: (2021-01-01)

Secondary Publication: The Pathophysiology of COVID-19 (Coronavirus Disease 2019) Caused by the Infection of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2)
by: Ayako Nakamura-Ishizu, et al.
Published: (2021-07-01)

Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children?
by: Rita Lauro, et al.
Published: (2021-04-01)

Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells
by: Susanna K.P. Lau, et al.
Published: (2020-12-01)

Neutrophil Extracellular Traps (NETs) in Severe SARS-CoV-2 Lung Disease
by: Monika Szturmowicz, et al.
Published: (2021-08-01)

Working Hypothesis for Glucose Metabolism and SARS-CoV-2 Replication: Interplay Between the Hexosamine Pathway and Interferon RF5 Triggering Hyperinflammation. Role of BCG Vaccine?
by: Hugo A. Laviada-Molina, et al.
Published: (2020-07-01)

Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19
by: Sara Lega, et al.
Published: (2020-05-01)